Literature DB >> 833468

The influence of fatty acids on the binding of bilirubin to albumin.

G B Odell, J O Cukier, E M Ostrea, A C Maglalang, R L Poland.   

Abstract

The influence of free fatty acids (FFA's) on the albumin binding of bilirubin was studied in vitro in the plasma of infants with neonatal hyperbilirubineamia and in solutions employing crystalline albumin to which bilirubin and FFA (oleic acid) were added. The bilirubin saturation index (SI) was utilized to distinguish between that fraction of bilirubin bound at the primary (high-affinity) site of albumin and bilirubin bound at secondary sites from which it is easily dissociated by salicylate. The relative saturation of albumin with bilirubin was also measured by addition of salicylate to whole blood samples where bilirubin was also measured by addition of salicylate to whole blood samples where bilirubin dissociated from the albumin could be sequestered by the red cells. The present studies indicate that FFA's influence the binding of bilirubin in two ways. At molar ratios of FFA to albumin (2:1 to 4:1), the FFA's compete with bilirubin for binding at the high-affinity site so that a significant portion of the bilirubin is transported at secondary sites, making it susceptible to displacement by water-soluble organic anions. At high molar ratios (greater than 5:1) FFA's compete with bilirubin for albumin binding at the secondary sites as well. In contrast to crystalline albumin where the first two molar equivalents of FFA do not influence the binding of bilirubin to albumin, all FFA concentrations in hyperbilirubinemic plasma reduce the affinity of albumin for bilirubin at its high-affinity site even though there is a molar excess of albumin over bilirubin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833468

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  9 in total

1.  Intravenous lipid and bilirubin-albumin binding variables in premature infants.

Authors:  Sanjiv B Amin; Theresa Harte; Lori Scholer; Hongyue Wang
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

2.  Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis.

Authors:  Domenico Lapenna; Giuliano Ciofani; Sante Donato Pierdomenico; Maria Adele Giamberardino; Sante Ucchino; Giovanni Davì
Journal:  Clin Exp Med       Date:  2017-09-25       Impact factor: 3.984

Review 3.  Bilirubin Binding Capacity in the Preterm Neonate.

Authors:  Sanjiv B Amin
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

4.  Effect of free fatty acids on bilirubin-albumin binding affinity and unbound bilirubin in premature infants.

Authors:  Sanjiv B Amin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2010 Jul-Aug       Impact factor: 4.016

5.  The effect of different intravenous lipids on free bilirubin levels in premature infants.

Authors:  Mehmet Satar; Hüseyin Şimşek; Ferda Özlü; Abdullah Tuli; Mustafa Muhlis Alparslan; Mustafa Kurthan Mert; Hacer Yapıcıoğlu Yıldızdaş
Journal:  Eur J Clin Nutr       Date:  2021-12-01       Impact factor: 4.884

Review 6.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

7.  Serum creatine kinase isoenzymes behavior in hepatic failure with encephalopathy.

Authors:  A Lemberg; M Schon; M C Macchi; L Galanternik; L Bengochea
Journal:  Dig Dis Sci       Date:  1981-10       Impact factor: 3.199

8.  Bilirubin/Albumin Ratio for Predicting Acute Bilirubin-induced Neurologic Dysfunction.

Authors:  Shahin Behjati Ardakani; Vahid Ghobadi Dana; Vahid Ziaee; Mohammad-Taghi Haghi Ashtiani; Gholamreza Esmaeeli Djavid; Mohsen Alijani
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

Review 9.  Intravenous lipids for preterm infants: a review.

Authors:  Ghassan Sa Salama; Mahmmoud Af Kaabneh; Mai N Almasaeed; Mohammad Ia Alquran
Journal:  Clin Med Insights Pediatr       Date:  2015-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.